Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
3.320
-0.290 (-8.03%)
At close: Mar 13, 2025, 4:00 PM
3.490
+0.170 (5.12%)
After-hours: Mar 13, 2025, 7:55 PM EST
Bionano Genomics Stock Forecast
BNGO's stock price has decreased by -94.78% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Bionano Genomics stock has a target of 60, which predicts an increase of 1,707.23% from the current stock price of 3.32.
Analyst Consensus: Hold
* Price targets were last updated on Aug 28, 2024.
Analyst Ratings
The average analyst rating for Bionano Genomics stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 10, 2024 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $360 → $60 | Buy → Hold | Downgrades | $360 → $60 | +1,707.23% | Aug 28, 2024 |
| BTIG | BTIG | Strong Buy Maintains $180 → $120 | Strong Buy | Maintains | $180 → $120 | +3,514.46% | May 16, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $420 → $360 | Buy | Maintains | $420 → $360 | +10,743.37% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
29.38M
from 36.12M
Decreased by -18.65%
Revenue Next Year
29.33M
from 29.38M
Decreased by -0.19%
EPS This Year
-81.70
from -408.60
EPS Next Year
-12.85
from -81.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 30.5M | 31.5M | 35.7M | |||
| Avg | 29.4M | 29.3M | 34.7M | |||
| Low | 28.0M | 27.0M | 33.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -15.7% | 7.2% | 21.7% | |||
| Avg | -18.6% | -0.2% | 18.3% | |||
| Low | -22.4% | -8.3% | 13.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -83.79 | -12.60 | -8.82 | |||
| Avg | -81.70 | -12.85 | -8.57 | |||
| Low | -78.79 | -12.94 | -8.23 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.